Switzerland
Swiss Drug Manufacturers—Specialty & Generic Industry Analysis
Benchmark and data visualization of Swiss public listed companies in the Drug Manufacturers—Specialty & Generic Industry, with top companies, stocks performance comparison, competitive analysis, and comparisons of top companies for market research.
Switzerland public listed companies in the Drug Manufacturers—Specialty & Generic industry: 4
Switzerland Drug Manufacturers—Specialty & Generic total companies market cap (USD): $17.47 Billion
format_list_bulleted
List of Swiss Drug Manufacturers—Specialty & Generic Companies
Switzerland Analysis
Top Swiss Companies
language World Companies Analysis language World Top Companies
Largest 4 Companies in the Swiss Drug Manufacturers—Specialty & Generic Industry by Market Cap
Top 4 Swiss Drug Manufacturers—Specialty & Generic Industry Companies Details as of July 1, 2025
| Company | Market Cap (USD) | Country | Sector | Industry |
|---|---|---|---|---|
| Vifor Pharma AG |
$11.57 B
(Dec. 1, 2022) |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
| Siegfried Holding AG | $5.03 B |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
| PolyPeptide Group AG | $876.3 M |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
| SES Solar, Inc. |
$None
(Jan. 11, 2021) |
Switzerland
|
Healthcare
|
Drug Manufacturers—Specialty & Generic
|
format_list_bulleted
List of Companies: Switzerland Drug Manufacturers—Specialty & Generic